Medical News

RSS

PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

Quintiles, the world's leading biopharmaceutical services company, and Population Genetics Technologies Ltd., creator of innovative solutions to reduce the costs and complexity of large-scale genomic testing and enable correlations with clinical outcomes, today announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

17 May 2011

Medicare trustees: Funds will run out sooner than expected

Last Friday, the Medicare trustees offered their annual take on the fiscal fitness of the health insurance program for senior citizens and the disabled. The reviews were worse than last year's projections.

17 May 2011

Wii Fit offers effective workout for patients with chronic obstructive pulmonary disease

According to a new study conducted by researchers in Connecticut, the Wii Fit- offers patients with chronic obstructive pulmonary disease an effective workout - and one that, because it is enjoyable, patients are more likely to use.

17 May 2011

Miniature, easy-to-carry ventilation system may help patients with COPD become more active

A miniature, easy-to-carry ventilation system with a simple nasal mask may help patients with chronic obstructive pulmonary disease become more active, according to research conducted at medical centers in California and Utah. The compact design offers an attractive alternative to currently available larger, less comfortableventilators and masks.

17 May 2011

State roundup: Calif. considers safety measures for mental hospitals

Nearly eight months after a Napa State Hospital patient strangled a psychiatric technician, lawmakers and employee groups are pushing proposals aimed at reversing a worsening safety trend at California's mental health facilities.

17 May 2011

Obese, asthmatic children more likely to experience excessive daytime sleepiness

Obese, asthmatic, anxious or depressed children are more likely to experience excessive daytime sleepiness, or EDS, according to Penn State College of Medicine sleep researchers.

17 May 2011

$Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment$

Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment

Medtronic, Inc. today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate bone cement for use in the treatment of spinal fractures with minimally invasive Kyphon Balloon Kyphoplasty.

From Medtronic 17 May 2011

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

AstraZeneca today announced results from a long-term study comparing SYMBICORT Inhalation Aerosol 160/4.5 mcg with budesonide pressurized metered-dose inhaler 160 mcg in self-reported African American patients with moderate to severe persistent asthma.

17 May 2011

Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study

The antibiotic linezolid may be more effective than vancomycin in treating ventilated patients who develop methicillin-resistant Staphylococcus aureus (MRSA) pneumonia as a result of their ventilation, according to a study conducted globally by American and French researchers.

17 May 2011

Comprehensive Care first quarter total revenue increases 383% to $18.3 million

Comprehensive Care Corporation today reported results for the first quarter ended March 31, 2011.

17 May 2011

Abcc10 might help counter resistance and extend effectiveness of anticancer drugs

Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens.

17 May 2011

Merck acquires Inspire Pharmaceuticals

Merck, known as MSD outside the United States and Canada, announced today that it is has completed its acquisition of Inspire Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing ophthalmic products, for $5.00 per share in cash.

17 May 2011

Viewpoints: Ryan on 'shared scarcity'; Romney fallout; Baltimore's ambitious health plan

Too many in Washington remain fixated on the next election, at the expense of the next generation. But there is a hidden cost to the shared scarcity mentality — a cost measured in lost prosperity and lost freedom. We face a choice between two futures. We can continue to go down the path toward shared scarcity, or we can choose the path of renewed prosperity.

17 May 2011

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, announced today that it has entered into an agreement with Sanofi to grant Sanofi a license for the development and commercialization of GBR 500, a novel monoclonal antibody for the treatment of Crohn's Disease and other inflammatory conditions.

17 May 2011

Perrigo's ANDA for generic Zantac 150 receives FDA final approval to treat heartburn

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter Ranitidine 150, a generic version of Zantac 150.

17 May 2011

Early stages of Alzheimer’s difficult to detect: Study

According to a new study, more than half of people who develop Alzheimer's disease before the age of 60 are initially misdiagnosed as having other kinds of brain disease when they do not have memory problems. The research is published in the May 17, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

17 May 2011

FDA nod for hepatitis C drug

Merck & Co have finally won the Food and Drugs Administration – FDA’S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.

17 May 2011

Histogenics announces acquisition of ProChon Biotech

Histogenics Corporation, a privately held regenerative medicine company, announced today that it has acquired ProChon Biotech, Ltd. in a stock-for-stock exchange.

17 May 2011

Imaginary bugs flummox dermatologists

It is known that some people have the “delusional bug syndrome” and are convinced that bugs, worms, germs, or other creepy crawlers are infesting their skin and often see skin doctor after skin doctor to find out what is causing the infestation. Often, patients bring in samples of the insect and request a skin biopsy.

17 May 2011

Life expectancy blood test not popular with experts

According to scientists and medical ethicist there are hidden dangers of a new blood test for determining how fast someone is ageing. The test costs £435 test and is due to go on sale to the general public in Britain later this year, measures the length of a person's telomeres, the structures on the tips of the chromosomes which get progressively shorter with age. Short telomeres are linked with age-related diseases and premature death.

17 May 2011

Medical News

PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

Medicare trustees: Funds will run out sooner than expected

Wii Fit offers effective workout for patients with chronic obstructive pulmonary disease

Miniature, easy-to-carry ventilation system may help patients with COPD become more active

State roundup: Calif. considers safety measures for mental hospitals

Obese, asthmatic children more likely to experience excessive daytime sleepiness

Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study

Comprehensive Care first quarter total revenue increases 383% to $18.3 million

Abcc10 might help counter resistance and extend effectiveness of anticancer drugs

Merck acquires Inspire Pharmaceuticals

Viewpoints: Ryan on 'shared scarcity'; Romney fallout; Baltimore's ambitious health plan

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Perrigo's ANDA for generic Zantac 150 receives FDA final approval to treat heartburn

Early stages of Alzheimer’s difficult to detect: Study

FDA nod for hepatitis C drug

Histogenics announces acquisition of ProChon Biotech

Imaginary bugs flummox dermatologists

Life expectancy blood test not popular with experts

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News